Research & development services to support preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91021D00019
- Awardee
-
University Of Pittsburgh - Of The Commonwealth System Of Higher Education UEI MKAGLD59JRL1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $91,021 obligated
Award facts
- Opportunity
-
- Preclinical Pharmacokinetic and Pharmacology Evaluations of Pre-Solicitation · 75N91021R00007 · Posted Mar 23, 2020
- Combined order value
-
- $91,021 Current, with exercised options
- $459,445 Potential, with all options
- Last date to order 72% complete
- IDV ceiling 1% used
- $9,900,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract IDV award by the National Cancer Institute (NCI), a civilian agency, provides for research and development services to support preclinical pharmacokinetic and pharmacology evaluations of agents being developed for cancer patients. The prime contractor is the University of Pittsburgh - Of The Commonwealth System of Higher Education, a major public research university with extensive experience conducting federal research contracts and grants across biomedical sciences.
The initial $459,445 delivery order is for pharmacokinetic and oral bioavailability studies in rats, supporting the NCI's work on new cancer therapies. This contract does not have a set-aside designation. The original solicitation was a Sources Sought notice seeking qualified small businesses to potentially implement bioanalytical methods and conduct pharmacokinetic evaluations of compounds for the NCI's Experimental Therapeutics program, with the goal of generating data to support the drug development process through early clinical trials. The contract has an ultimate completion date of September 2028 and a $9.9 million ceiling value, enabling the NCI to rapidly initiate preclinical studies across multiple research areas related to cancer and infectious disease treatments.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pharmacokinetic and oral bioavailability studies in rats | National Cancer Institute (NIH) | $91,021 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91021D00019?
75N91021D00019 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Cancer Institute (National Institutes of Health) on September 27, 2021.
How much is contract 75N91021D00019 worth?
Orders under 75N91021D00019 have obligated $91,021. Their combined potential value, with all options, is $459,445. 75N91021D00019's own ceiling is $9,900,000.
How many orders have been placed under contract 75N91021D00019?
1 order has been placed under 75N91021D00019, the latest on September 25, 2023.
Who can order from contract 75N91021D00019?
75N91021D00019 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91021D00019 competed?
The extent of competition for 75N91021D00019 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV